SAN FRANCISCO and BOSTON, March 24, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing…
Scottsdale, AZ, March 24, 2026 (GLOBE NEWSWIRE) -- MitoSynergy, a science-driven wellness company focused on cellular and mitochondrial health, today…
March 24, 2026 17:30 ET | Source: BioSyent Inc. MISSISSAUGA, Ontario, March 24, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”…
Amsterdam – HERE Technologies, the leading mapping and location data platform, today announced that it has joined DCSA+, the partnership programme…
SHENZHEN, China, March 24, 2026 (GLOBE NEWSWIRE) -- ONERugged, a brand of Emdoor Information Co., Ltd., recently introduced the V82T,…
HongKong, March 24, 2026 (GLOBE NEWSWIRE) -- The Apexmind Summit 2026 was grandly held in Hong Kong today. The summit…
Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease…
Idorsia nominates three Board Directors with outstanding pharmaceutical industry, management and financial expertise for election at the Annual General Meeting…
Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in…
BASEL, Switzerland, March 23, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage preclinical biotech focused on reprogramming the immune system with…